ARTV
Artiva Biotherapeutics, Inc.
6.90$
+2.1%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -14.2% | -15.8% | +197.2% | -7.1% | -8.7% | -11.4% | -12.1% | -12.0% | -19.1% | +247.9% | |
| – | – | -17.5% | -24.5% | +202.6% | +25.3% | -9.9% | -12.3% | -13.1% | -13.0% | -21.2% | +297.0% | |
| – | – | -9.9% | -28.9% | +63.2% | -28.0% | -24.4% | -6.4% | -10.4% | +4.7% | -21.5% | +1,338.6% | |
| – | – | -19.3% | -25.1% | +215.0% | +26.5% | -10.5% | -14.2% | -13.6% | -12.2% | -19.7% | +302.6% | |
| – | – | -2.0% | -15.2% | -52.0% | -79.2% | +608.2% | -97.1% | +2,830.0% | -12.7% | -21.8% | -76.5% | |
| – | – | -0.9% | +0.8% | -90.8% | -6.7% | -2.0% | -9.5% | -3.5% | +6.8% | -13.6% | +16.7% | |
| – | – | -15.2% | +4.4% | +22.8% | -7.8% | -0.4% | -11.8% | +3.3% | +17.7% | -16.9% | +34.0% | |
| – | – | +1.4% | +3.9% | -1.5% | +0.2% | -0.5% | -2.1% | -12.9% | -3.6% | -0.8% | +8.7% | |
| – | – | +141.5% | -44.5% | +47.6% | -7.7% | +81.6% | -40.3% | -30.2% | -58.1% | +543.9% | -39.4% | |
| – | – | – | – | – | -7.1% | -9.6% | -11.7% | -13.3% | -14.9% | -20.1% | +295.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.5% | -13.9% | +32.4% | +4.3% | +0.3% | -0.1% | +0.2% | +0.4% | -0.2% | +1.0% | +59.7% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.